Скачать или смотреть India Fights Back : COVAXIN Efficacy Report

In this edition of the show, we’ll focus on the vaccination drive and the efficacy reports of Covaxin – one of the two indigenous vaccines being administered in India for the Covid-19. Covaxin has demonstrated interim clinical efficacy of 81 per cent in its phase three trial. The trial involved 25 thousand 800 participants across 21 sites.

Developed by Bharat Biotech in partnership with the Indian Council of Medical Research, these results of the phase 3 clinical trial is also a testament to India’s emergence as a global vaccine superpower.

Anchor - Rajat Kain
Producer- Saumya Nanda

GUESTS
a. Dr Alok Kumar Deb, Scientist, ICMR-NICED, Kolkata

b. Dr. Anant Mohan, HOD, Pulmonary Medicine, AIIMS, Delhi